These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38115318)

  • 1. Construction of monocyte-related prognosis model based on comprehensive analysis of bulk RNA-seq and single-cell RNA-seq in high-grade serous ovarian cancer.
    Xu Y; Tan S; Huang W; Wang YX
    Medicine (Baltimore); 2023 Dec; 102(50):e36548. PubMed ID: 38115318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
    Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
    J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of an ovarian cancer exhausted CD8+T cells-related genes model by integrated analysis of scRNA-seq and bulk RNA-seq.
    Hua T; Liu DX; Zhang XC; Li ST; Wu JL; Zhao Q; Chen SB
    Eur J Med Res; 2024 Jul; 29(1):358. PubMed ID: 38970067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four genes relevant to pathological grade and prognosis in ovarian cancer.
    Pan X; Chen Y; Gao S
    Cancer Biomark; 2020; 29(2):169-178. PubMed ID: 32444534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and validation of a novel risk model based on CD8T cell marker genes to predict prognosis in thyroid cancer by integrated analysis of single-cell and bulk RNA-sequencing.
    Du J; Song CF; Wang S; Tan YC; Wang J
    Medicine (Baltimore); 2023 Oct; 102(42):e35192. PubMed ID: 37861558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis.
    Wu M; Sun Y; Wu J; Liu G
    Med Sci Monit; 2020 Mar; 26():e922107. PubMed ID: 32180586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of an individualized gene expression-based signature to predict overall survival of patients with high-grade serous ovarian carcinoma.
    Yuan D; Zhu H; Wang T; Zhang Y; Zheng X; Qu Y
    Eur J Med Res; 2023 Oct; 28(1):465. PubMed ID: 37884970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling.
    Yang H; Wang Z; Gong L; Huang G; Chen D; Li X; Du F; Lin J; Yang X
    Int J Genomics; 2022; 2022():8594658. PubMed ID: 35634481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of SPOCK2 expression signature for high-grade serous ovarian cancer patients.
    Jiao M; Sun W; Li L; Li C; Zhou J; Li Q; Duan L
    Front Genet; 2022; 13():878123. PubMed ID: 36246613
    [No Abstract]   [Full Text] [Related]  

  • 11. Integration of scRNA-Seq and Bulk RNA-Seq to Analyse the Heterogeneity of Ovarian Cancer Immune Cells and Establish a Molecular Risk Model.
    Liang L; Yu J; Li J; Li N; Liu J; Xiu L; Zeng J; Wang T; Wu L
    Front Oncol; 2021; 11():711020. PubMed ID: 34621670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Specific Cell Subpopulations and Marker Genes in Ovarian Cancer Using Single-Cell RNA Sequencing.
    Li Y; Wang J; Wang F; Gao C; Cao Y; Wang J
    Biomed Res Int; 2021; 2021():1005793. PubMed ID: 34660776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated Analysis To Identify Molecular Biomarkers Of High-Grade Serous Ovarian Cancer.
    Si M; Zhang J; Cao J; Xie Z; Shu S; Zhu Y; Lang J
    Onco Targets Ther; 2019; 12():10057-10075. PubMed ID: 31819501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.
    Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
    J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel sepsis prognosis model and analysis of possible drug application prospects: Based on scRNA-seq and RNA-seq data.
    He H; Huang T; Guo S; Yu F; Shen H; Shao H; Chen K; Zhang L; Wu Y; Tang X; Yuan X; Liu J; Zhou Y
    Front Immunol; 2022; 13():888891. PubMed ID: 36389695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Analysis of 5-Methylcytosine Profiles of Messenger RNA in Human High-Grade Serous Ovarian Cancer by MeRIP Sequencing.
    Meng L; Zhang Q; Huang X
    Cancer Manag Res; 2021; 13():6005-6018. PubMed ID: 34377020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune profiling reveals prognostic genes in high-grade serous ovarian cancer.
    Wu Y; Xia L; Zhao P; Deng Y; Guo Q; Zhu J; Chen X; Ju X; Wu X
    Aging (Albany NY); 2020 Jun; 12(12):11398-11415. PubMed ID: 32544083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a prognostic model for ovarian cancer based on mitochondrial metabolism-related genes.
    Meng C; Sun Y; Liu G
    Front Oncol; 2023; 13():1144430. PubMed ID: 37256178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative Stress Response Biomarkers of Ovarian Cancer Based on Single-Cell and Bulk RNA Sequencing.
    Zheng M; Hu Y; Liu O; Li S; Wang Y; Li X; Liu J; Yang Q; Li X; Lin B
    Oxid Med Cell Longev; 2023; 2023():1261039. PubMed ID: 36743693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
    Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
    Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.